Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
QuintilesIMS
Colorcon
Citi
McKinsey
Teva
US Department of Justice
Chubb
Farmers Insurance

Generated: April 21, 2018

DrugPatentWatch Database Preview

ZARONTIN Drug Profile

« Back to Dashboard

Which patents cover Zarontin, and when can generic versions of Zarontin launch?

Zarontin is a drug marketed by Parke Davis and Parke-davis and is included in two NDAs.

The generic ingredient in ZARONTIN is ethosuximide. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the ethosuximide profile page.
Drug patent expirations by year for ZARONTIN
Medical Subject Heading (MeSH) Categories for ZARONTIN
Synonyms for ZARONTIN
.alpha.-Ethyl-.alpha.-methylsuccinimide
.alpha.-Methyl-.alpha.-ethylsuccinimide
.gamma.-Methyl-.gamma.-ethylsuccinimide
(.+/-.)-Ethosuximide
(+-)-2-Ethyl-2-methylsuccinimide
(+/-)-2-ethyl-2-methylsuccinimide
2-Ethyl-2-methylsuccinimide
2-Methyl-2-ethylsuccinimide
2, 3-ethyl-3-methyl-
2, 5-Pyrrolidinedione, 3-ethyl-3-methyl-
2,5-Pyrrolidinedione, 3-ethyl-3-methyl-
2,5-Pyrrolidinedione, 3-ethyl-3-methyl-, (+-)-
3-Ethyl-3-methyl-2, 5-pyrrolidinedion
3-Ethyl-3-methyl-2, 5-pyrrolidinedione
3-Ethyl-3-methyl-2,5-pyrrolidinedione
3-ethyl-3-methyl-pyrrolidine-2,5-dione
3-Ethyl-3-methyl-pyrrolidine-2,5-dione (ethosuximide)
3-Ethyl-3-methyl-pyrrolidine-2,5-dione(Ethosuximide)
3-ethyl-3-methylazolidine-2,5-dione
3-Ethyl-3-methylpyrrolidine-2,5-dione
3-Ethyl-3-methylpyrroline-2,5-dione
3-Ethyl-3-methylsuccinimide
3-ethyl-5-hydroxy-3-methyl-3,4-dihydro-2H-pyrrol-2-one
3-Methyl-3-ethylpyrrolidine-2,5-dione
3-Methyl-3-ethylsuccinimide
4-ethyl-5-hydroxy-4-methyl-3,4-dihydro-2H-pyrrol-2-one
5-21-09-00595 (Beilstein Handbook Reference)
77-67-8
AB00052288
AB00052288_04
AC1L1FLN
AC1Q2SOO
Aethosuccimidum
Aethosuximide
Aethosuximide [German]
AKOS005261742
alpha-Ethyl-alpha-methylsuccinimide
alpha-Methyl-alpha-ethylsuccinimide
AN-23917
ANW-41860
AOB5337
AS-16859
Asamid
Atysmal
BDBM50240424
BPBio1_000033
BRD-A99633051-001-04-7
BRN 0117054
BSPBio_000029
C.I. 366
C07505
Capitus
CAS-77-67-8
CCG-39217
CHEBI:4887
CHEMBL696
CI 366
CI-366
Cl 366
CN-10,395
CN-10395
CS-7976
CTK8B3160
D00539
D0Q4XQ
DB00593
Desitin Brand of Ethosuximide
DivK1c_000218
DSSTox_CID_3019
DSSTox_GSID_23019
DSSTox_RID_76832
DTXSID7023019
E 7138
E0746
EINECS 201-048-7
Emeside
Epileo Petit MAL
Ethosuccimid
Ethosuccimide
Ethosuccinimide
Ethosuxide
Ethosuximid
ethosuximide
Ethosuximide (JP15/USP/INN)
Ethosuximide (JP17/USP/INN)
Ethosuximide [USAN:INN:BAN:JAN]
Ethosuximide 1.0 mg/ml in Methanol
Ethosuximide, analytical standard
Ethosuximide, European Pharmacopoeia (EP) Reference Standard
Ethosuximide, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Ethosuximide, United States Pharmacopeia (USP) Reference Standard
Ethosuximidum
Ethosuximidum [INN-Latin]
Ethylmethylsuccimide
Ethymal
Etomal
Etosuccimide
Etosuccimide [DCIT]
Etosuximid
Etosuximida
Etosuximida [INN-Spanish]
Etosuximida Faes
Etosuximide
EU-0100532
Faes Brand of Ethosuximide
Faes, Etosuximida
Fortbenton Brand of Ethosuximide
FT-0668060
gamma-ethyl-gamma-methyl-succinimide
gamma-Methyl-gamma-ethyl-succinimide
gamma-Methyl-gamma-ethylsuccinimide
GTPL7182
H 940
H-490
HAPOVYFOVVWLRS-UHFFFAOYSA-N
HE030955
HE300385
HE388133
HMS1568B11
HMS1921L14
HMS2092D20
HMS2095B11
HMS3261L05
HMS500K20
HSDB 1119
HY-B1378
IDI1_000218
Jenapharm Brand of Ethosuximide
Katwijk Brand of Ethosuximide
KBio1_000218
KBio2_001865
KBio2_004433
KBio2_007001
KBio3_002008
KBioGR_001342
KBioSS_001865
LAB Brand of Ethosuximide
Lopac0_000532
LP00532
LS-147585
MCULE-4034034545
Mesentol
MFCD00072123
MolPort-003-666-417
N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(2-(2-methyl-1,3,4-oxadiazole-5-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide
N-Ethyl methylsuccinimide
NCGC00015418-02
NCGC00015418-03
NCGC00015418-04
NCGC00015418-05
NCGC00015418-06
NCGC00015418-08
NCGC00015418-09
NCGC00016320-01
NCGC00093923-01
NCGC00093923-02
NCGC00093923-03
NCGC00093923-04
NCGC00261217-01
NCIOpen2_000014
NE54559
NINDS_000218
NSC 64013
NSC-64013
NSC-758192
NSC64013
NSC758192
Parke Davis Brand of Ethosuximide
Pemal
Pemalin
Pentinimid
Peptinimid
Petinimid
Petnidan
Pfizer Brand of Ethosuximide
Pharmakon1600-01502196
Piknole.psi.n
Piknolepsin
PM 671
PM-671
Prestwick_611
Prestwick0_000165
Prestwick1_000165
Prestwick2_000165
Prestwick3_000165
Pyknole.psi.num
Pyknolepsinum
Ronton
s4626
SBI-0050515.P003
SC-65415
SCHEMBL34212
Simatin
Simatin(E)
SPBio_001465
SPBio_001950
Spectrum_001385
SPECTRUM1502196
Spectrum2_001483
Spectrum3_000944
Spectrum4_001051
Spectrum5_001073
SR-01000075863
SR-01000075863-1
ST51037248
Succimal
Succimitin
Succinimide, 2-ethyl-2-methyl-
Suksilep
Suxilep
Suximal
Suxin
Suxinutin
Thetamid
Thilopemal
Tox21_110370
Tox21_110370_1
Tox21_500532
United Drug Brand of Ethosuximide
W-109273
Warner Lambert Brand of Ethosuximide
Warner-Lambert Brand of Ethosuximide
Wernigerode Brand of Ethosuximide
WLN: T5VMVTJ D2 D1
Z2379802739
Zaraondan
Zarodan
Zarondan
Zarondan-Saft
Zarontin (TN)
zarontin3-Ethyl-3-methyl-pyrrolidine-2,5-dione
Zartalin

US Patents and Regulatory Information for ZARONTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis ZARONTIN ethosuximide CAPSULE;ORAL 012380-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Parke-davis ZARONTIN ethosuximide SYRUP;ORAL 080258-001 Approved Prior to Jan 1, 1982 AA RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Argus Health
Daiichi Sankyo
Teva
AstraZeneca
Accenture
UBS
QuintilesIMS
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.